Recent News

Managing cancer pain during the opioid crisis: A multidisciplinary, cross-Canada knowledge dissemination and research planning initiative

Canada’s current opioid crisis, and efforts to curb it, may be contributing to inadequate cancer pain management.
 
This was the core takeaway of the first step in a ground-breaking national initiative to highlight the impact of the opioid crisis on cancer pain management and develop a research agenda investigating the crisis and ways to optimize pain management across the disease continuum and the lifespan.

National Pain Awareness Week - November 3 - 10, 2019

The first week of November is the Pain Awareness Week across Canada. Did you know that 20% of the population lives with chronic pain? No wonder the Federal Minister of Health has created a Canadian Pain Task Force! Several activities will be offered during the next week. Check out some of these activities on the Canadian Pain Society website.

First report of the Canadian Pain Task Force

In the wake of the creation of the Canadian Pain Task Force, the first report was produced in June 2019. The conclusions are: 1 / limited access to services for people living with pain; 2 / stigma and undue suffering. The report concludes: "Canadians living with pain and their loved ones simply deserve better."

To access the first report, click HERE

Creation of a Canadian Pain Task Force

The Honorable Minister Petitpas-Taylor is calling for the creation of a national pain task force to gather more information on the prevention, treatment and management of chronic pain affecting 20% of the Canadian population. The announcement was made at the 40th Scientific Conference of the Canadian Pain Society. A first report highlighting the state of affairs in this sector should be available by the summer of 2019.

Appointment of Serge Marchand as vice-president of scientific affairs at Genome Quebec

Dr. Serge Marchand, professor at the Department of Surgery - Service of Neurosurgery at the Université de Sherbrooke for 15 years, member of the Pain Network Executive Committee from 2015 to 2017, then appointed as scientific director for the Quebec Health Research Fund from 2017 to 2019. In 2019, he is appointed as vice-president of scientific affairs at Genome Quebec, in order to promote interdisciplinary and intersectoral collaboration in the field of genomics.

Serge Marchand named Scientific Director of the FRQ-S

Serge Marchand

Congratulations to Serge Marchand for his nomination as Scientific Director of the Fonds de recherche du Québec - Santé, annonced today by government of Québec. Serge Marchand is full Professor at Université Sherbrooke, and a researcher affiliated to the Centre de recherche du Centre hospitalier universitaire de Sherbrooke (CHUS).  He works in a group on Pain and Inflammation, an axis he has created and developed himself over the last few years.  His work have shed light on the neurophysiological mechanisms responsible for the development and persistence of chronic pain. 

Sylvine Cottin shows peripheral nerve field stimulation helps alleviate pain

New results by Sylvine Cottin, Université Laval, shows that peripheral nerve field stimulation is an effective means to alleviate overall pain by over 50% in patients with low back pain.  The  results were presented at the 2017 annual meeting of the North American Neuromodulation Society.  Read more about this study on the Pain Medicine News website:

Interview with Catherine Ferland on Salut Bonjour about Essentrics training

Listen to a recent interview with Catherine Ferland on the television show Salut Bonjour, in which she discusses the positive effects of Essentrics training for people suffering from chronic pain.  View this interview by Marie-Ève Gosemick, Well-Being correspondent, here (in French only):  

http://tva.canoe.ca/emissions/salutbonjour/chroniques/detail/l-entrainement-essentrics-et-ses-bienfaits

Jeff Mogil explains the placebo effect in Vox

Read a recent article in Vox in which Jeffrey Mogil explains  that “the placebo response is growing bigger over time,” but only in the US.  This effect helps explain why fewer and fewer new pain drugs were getting through double-blind placebo control trials, the gold standard for testing a drug’s effectiveness.

Read more about this discovery in Vox:

The weird power of the placebo effect, explained | Yes, the placebo effect is all in your mind. And it’s real.

Pages